or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    BAX C Baxter International Inc. -0.25
    CPRX D Catalyst Pharmaceutical Partners, Inc. 1.43
    CGTX B Cognition Therapeutics, Inc. 1.04
    CORT D Corcept Therapeutics Incorporated 2.66
    DXR B Daxor Corporation 0.00
    ELDN B Eledon Pharmaceuticals, Inc. 1.98
    ELYM B Eliem Therapeutics, Inc 17.40
    XGN F Exagen Inc. 0.15
    FULC D Fulcrum Therapeutics, Inc. 0.14
    IGC B India Globalization Capital Inc. 6.51
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Medicine Epilepsy Pharmaceutical Alzheimer's Disease Biopharmaceutical Clinical Medicine Disease Health Sciences Kidney Failure Medication Pain Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Alpha 1 Antitrypsin Anemia Antiprogestogens Antitrypsin Deficiency Audiology Autoimmune Disease

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 6.53
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 3.97
    JSML C Janus Small Cap Growth Alpha ETF 3.93
    PJP C PowerShares Dynamic Pharmaceuticals 3.8
    XPH D SPDR S&P Pharmaceuticals ETF 3.75
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to JSML Compare JSML to XPH Compare SURI to JSML

        Disorders Stocks Recent News

        Date Stock Title
        Apr 25 BAX ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
        Apr 24 CORT Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
        Apr 23 CORT Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
        Apr 22 CORT Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
        Apr 22 CORT Corcept falls after phase 3 results on Cushing's candidate doesn't include some data
        Apr 22 CORT Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
        Apr 22 CPRX Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
        Apr 22 CGTX Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Medicine Epilepsy Pharmaceutical Alzheimer's Disease Biopharmaceutical Clinical Medicine Disease Health Sciences Kidney Failure Medication Pain Parkinson's Disease Psychiatric Diagnosis Aging Associated Diseases Alpha 1 Antitrypsin Anemia Antiprogestogens Antitrypsin Deficiency Audiology Autoimmune Disease
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags